ChemoCentryx
CCXI
#3639
Rank
HK$29.21 B
Marketcap
HK$406.18
Share price
0.00%
Change (1 day)
34.02%
Change (1 year)

Market capitalization of ChemoCentryx (CCXI)

Last known market cap: HK$29.21 Billion

On November 25, 2022 ChemoCentryx had a market cap of HK$29.21 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of ChemoCentryx from 2012 to 2022

End of year Market Cap

Year Marketcap Change
2022HK$29.21 B46.94%
2021HK$19.88 B-40.15%
2020HK$33.22 B79.06%
2019HK$18.55 B328.74%
2018HK$4.32 B90.89%
2017HK$2.26 B-17.36%
2016HK$2.74 B-1.11%
2015HK$2.77 B20.52%
2014HK$2.30 B19.53%
2013HK$1.92 B-37.54%
2012HK$3.08 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
HK$4.277 T 14,542.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$1.174 T 3,920.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$3.079 T 10,441.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$1.438 T 4,823.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$206.17 B 605.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$2.151 T 7,266.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$875.55 B 2,897.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$814.75 B 2,689.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$305.47 B 945.69%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel